Snapshot from Nov 22, 2026 at 07:00 UTC. For live data and tracking: View Live
Entity

Sahajanand Medical Technologies

Tracked across 1 events · 6 articles · First seen Sep 09, 2026 · Last active Sep 09, 2026

Sentiment
60
Attention
2
Events
1
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
2 60
Regulatory
Sahajanand Medical Technologies Limited (SMT) received a Class IV medical device license from Canada — Health Canada's Medical Devices Directorate for its Supraflex Cruz sirolimus-eluting coronary stent system. This approval allows the device to be…
Impact: Received regulatory approval from Canada — Health Canada for its Supraflex Cruz stent, expanding market access and supporting its pre-IPO growth narrative.
Sep 09, 2026 · 6 articles
ERGEN INTELLIGENCE
Track Sahajanand Medical Technologies live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.